An increasing amount of evidence is suggesting the potential usefulness of growth factors, such as IGF-I, as potential treatments for certain neurodegenerative diseases, including ALS and AD due to its neurotrophic effect [54]. The gene discussed is IGF1; the disease is Alzheimer disease.